Application Note: Pioneering Research Into Versatile New Therapeutic Systems
20 February 2019
Many emerging viral infections can lead to life-threatening complications involving the central nervous system – including encephalitis or meningitis. But treatment can be challenging, due to difficulties with delivering antiviral drugs across the blood-brain-barrier. A recent study published in Drug Delivery demonstrates the potential of a new inhaled powdered formulation for the direct nose-to-brain delivery of the antiviral drug ribavirin (RBV).